Skip to main content
Year archive

Hutchmed (China) Limited — 2013 filings

All 23 regulatory filings released by Hutchmed (China) Limited (HCM) in 2013, sourced directly from the official regulator.

23 Filings
2013 Period
2013 filings (23)
Filing Released Lang
Blocklisting Six Monthly Return
Regulatory Filings
2013-12-30 English
Sinopharm distribution joint venture in China
Regulatory Filings
2013-12-18 English
Director/PDMR Shareholding
Director's Dealing
2013-10-16 English
Payment From Janssen Pharmaceuticals
Regulatory Filings
2013-10-09 English
Analyst & Investor Briefing
Regulatory Filings
2013-10-09 English
Lilly Deal for Fruquintinib
Regulatory Filings
2013-10-09 English
Analyst briefing on Chi-Med's R&D business
Regulatory Filings
2013-10-03 English
Holding(s) in Company
Major Shareholding Notification
2013-09-13 English
Director/PDMR Shareholding
Director's Dealing
2013-08-08 English
Interim Results
Interim / Quarterly Report H1 2013
2013-07-30 English
Global Phase III HPML-004 maintenance study starts
Regulatory Filings
2013-07-17 English
Blocklisting Interim Review
Regulatory Filings
2013-07-01 English
Volitinib Phase I triggers US$5 million milestone
Regulatory Filings
2013-06-25 English
Notice of Results
Report Publication Announcement
2013-06-24 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2013-05-10 English
Global Phase III UC trial initiated with HPML-004
Regulatory Filings
2013-04-24 English
Nutrition Science Partners JV Approved
Regulatory Filings
2013-04-12 English
2012 Annual Report and Notice of AGM
Report Publication Announcement
2013-04-09 English
Data Presentations at AACR
Regulatory Filings
2013-04-08 English
Final Results
Annual Report FY 2012
2013-03-26 English
Total Voting Rights
Regulatory Filings
2013-02-28 English
Notice of Results
Report Publication Announcement
2013-02-18 English
Holding(s) in Company
Major Shareholding Notification
2013-01-28 English